probiotics in Irritable bowel syndrome

Phase 3

Recruiting

• Conditions: Irritable bowel syndrome.; Irritable bowel syndrome

• Registration Number: IRCT20181231042191N1
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 23 April 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients will be selected based on the Rome II criteria according to the gastroenterologist diagnosis ; (Rome II criteria: abdominal pain or any digestive discomfort for at least 3 months during the last year that can be consecutive or non-consecutive, along with two of the three following items: relieving pain by defecation, starting symptoms associated with change in the frequency of bowel movements, starting symptoms associated with change in the shape of feces)
Age of at least 18 years old
The informed consent of the patient, which is submitted in writing form after all necessary explanations are given to him/her.

Exclusion Criteria

History of major gastrointestinal surgery
chronic use of antibiotics, corticosteroids and immunosuppressive drugs
Regular use of drugs that alter gastrointestinal movements such as metoclopramide, cisapride, domperidone, narcotics especially opioid derivatives, laxatives, anti-diarrheal agents, as well as other effective drugs for the treatment of IBS, as described in more detail in the text.
Presence of severe psychological and behavioral disorders in the patient
Food allergy
History of any organic bowel disease or chronic digestive illness

Study & Design

• Study Type: interventional
• Study Design: Not specified